BAT (Cangene Corporation)
Welcome to the PulseAid listing for the BAT drug offered from Cangene Corporation. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | Cangene Corporation |
| NON-PROPRIETARY NAME: | Botulism Antitoxin Heptavalent |
| SUBSTANCE NAME: | EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2013-03-01 |
| END MARKETING DATE: | 0000-00-00 |
BAT PLASMA DERIVATIVE Details:
| Item Description | BAT from Cangene Corporation |
| LABELER NAME: | Cangene Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4500; 3300; 3000; 600; 5100; 3000; 600([iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL; [iU]/10mL) |
| START MARKETING DATE: | 2013-03-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 60492-0075_917691ee-4d8b-468f-8cc5-b64c0688e4ae |
| PRODUCT NDC: | 60492-0075 |
| APPLICATION NUMBER: | BLA125462 |
Other EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2; EQUINE BOTULINUM NEUROTOXIN Pharmaceutical Manufacturers / Labelers:
